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Abstract
Mice and guinea pigs were experimentally exposed to aerosols containing regionally-distinct strains
(NJ1959 or ArgM) of eastern equine encephalitis virus (EEEV) at two exclusive particle size
distributions. Mice were more susceptible to either strain of aerosolized EEEV than were guinea
pigs; however, clinical signs indicating encephalitis were more readily observed in the guinea pigs.
Lower lethality was observed in both species when EEEV was presented at the larger aerosol
distribution (> 6 μm), although the differences in the median lethal dose (LD50) were not significant.
Virus isolation and immunohistochemistry indicated that virus invaded the brains of guinea pigs
within one day postexposure, regardless of viral strain or particle size distribution.
Immunohistochemistry further demonstrated that neuroinvasion occurred through the olfactory
system, followed by transneuronal spread to all regions of the brain. Olfactory bipolar neurons and
neurons throughout the brain were the key viral targets. The main microscopic lesions in infected
guinea pigs were neuronal necrosis, inflammation of the meninges and neuropil of the brain, and
vasculitis in the brain. These results indicate that guinea pigs experimentally infected by aerosolized
EEEV recapitulate several key features of fatal human infection and thus should serve as a suitable
animal model for aerosol exposure to EEEV.
Introduction
Eastern equine encephalitis (EEE) virus (EEEV) are a
group of positive-strand RNA viruses in the genus Alphavi-
rus, family Togaviridae, that cause significant morbidity
and death in infected animals and humans [1-3]. The
related alphaviruses Venezuelan equine encephalitis virus
(VEEV) and western equine encephalitis virus (WEEV)
also cause encephalitis and significant morbidity in
humans and equines. Although naturally transmitted by
mosquitoes, laboratory infections with these viruses [4]
and experimental studies in animals have demonstrated
that all three alphaviruses are infectious by the aerosol
route and are considered a potential biowarfare threat.
Natural outbreaks of EEE have been reported primarily in
North America; the South American varieties of EEEV
appear to be less virulent in humans and animal models
[5,6]. At a nucleotide level, South American strains in gen-
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eral are 25-38% different from North American strains
[5]. In humans, the clinical disease and sequelae associ-
ated with EEEV infection are the most severe of any
alphavirus, with an estimated mortality rate in humans of
30% for the North American strains [7]. The pathogenic
effects of EEE in humans, horses, cows, and pigs have
been clinically described in case reports from sporadic
outbreaks in North and South America [[3,8], Jordan,
1965 #182, [9]]. In humans, EEEV infection results in a
rapid onset of clinical signs and symptoms after exposure
characterized by lethargy, hyperthermia, emesis, severe
headache, and generalized malaise. Children, in particu-
lar, are susceptible. Pathologically, EEEV targets neurons
in the brain, leading to widespread meningoencephalitis
with neuronal necrosis, the formation of perivascular
cuffs, and infiltration of the meninges and neuropil by
neutrophils and mononuclear cells [7,10,11]. Vasculitis is
also considered a key pathological feature of EEEV infec-
tion in humans. The disease rapidly progresses to severe
hyperthermia, and coma, with death 5-15 days postinfec-
tion. Even among survivors, long-term neurological com-
plications are common [11].
A variety of animal species have been investigated as pos-
sible disease models of human EEE. Limited pathogenic-
ity studies using EEEV have been performed in pigs [12]
and calves [13] using intraperitoneal, intranasal, or intrac-
ranial routes of exposure. Approximately 48-72 hr after
exposure of those animal species, mild to moderate neu-
rological signs appeared, manifesting as lethargy, somno-
lence, altered gait, incoordination, circling, recumbency,
and paddling movements. Subcutaneous inoculation of
EEEV is rarely fatal to adult mice; however, lethal infection
can be induced in mice 3-5 weeks old [14,15]. Fibroblasts
in the vicinity of the inoculation sites, osteoblasts in
actively growing bone, and skeletal muscle myocytes are
considered important cell types that support early viral
amplification in young mice inoculated subcutaneously,
but EEEV in mice has also has been shown to infect mac-
rophages, dendritic cells, synovial cells, fibroblasts in sev-
eral locations, keratinocytes, sebaceous glands, cardiac
myofibers, retinal ganglion cells, and odontoblastic and
ameloblastic epithelia of teeth [15]. Viremia develops rap-
idly, peaking at around 12 hr after subcutaneous inocula-
tion and preceding neuroinvasion. Surprisingly, EEEV
does not appear to enter into the brain through the olfac-
tory bulb, as has been shown to be the case for VEEV and
Sindbis virus infection [16-19]. Golden hamsters have
been proposed as an additional disease model for natural
EEEV infection, as they reportedly develop the vasculitis
that is observed in human but not murine infections [20].
In cynomolgus macaques, aerosol exposure to EEEV
results in fever and lethal encephalitis [21]. Virus isolation
and immunohistochemistry indicated high viral titers in
the brain and spinal cord. Vasculitis, which is reported in
humans, was not seen in the macaques (Jo Lynne Ray-
mond, unreported data).
Vaccines and therapeutics that protect against EEEV infec-
tion are needed to protect against the biowarfare threat
posed by aerosolized EEEV. Demonstrating efficacy
against aerosol exposure to EEEV would not be possible in
a human clinical trial as inhalation is not a natural route
of EEEV transmission. Licensure is only possible through
the FDA's 'Animal Rule', which allows for the demonstra-
tion of efficacy in multiple well-characterized, relevant
animal models [22]. Because experimental studies have
demonstrated antigenic differences between North Amer-
ican and South American strains of EEEV, it will be impor-
tant to demonstrate protection against strains from both
geographic origins in suitable animal models [6]. A survey
of the available disease models for EEEV revealed that few
available studies address animal species susceptibility or
regional viral strain virulence in experimental aerosol
infection. Further, there are no reports of differential path-
ogenicity of aerosolized EEEV when presented at distinctly
different particle size distributions in any laboratory ani-
mal species.
The objective of this study was to initially assess the sus-
ceptibility of mice and guinea pigs to aerosolized EEEV
and to describe the resulting pathology associated with
experimental infection. Initially, to assess susceptibility
and derive lethality estimates, groups (n = 8) of mice and
guinea pigs were exposed by aerosol using either a North
(NJ1959) or South American (ArgM) strains of EEEV pre-
sented at two distinctly different particle size distribu-
tions. We performed five target doses (x5) per viral strain
(x2) per species (x2) per aerosol size distribution (x2) for
a total of 40 individual experiments. Thereafter, groups of
guinea pigs were exposed to either strain of EEEV (x2) at
either aerosol size distribution (x2) to further distinguish




Female BALB/c mice and Hartley guinea pigs of both sexes
were obtained from Charles River Laboratories (National
Cancer Institute, Fort Detrick, MD). The mice were
approximately 19-22 g and 8-9 weeks old; the guinea pigs
were 8-10 weeks old and approximately 250 g at the time
of exposure. Animals were provided with rodent chow
and water ad libitum and maintained on a 12 hr light/dark
cycle.
Reagents & Virus
North American (New Jersey 1959; NJ1959) and South
American (Argentina M; ArgM) strain of the EEEV were
used in the experimentation. Viruses were propagated inVirology Journal 2009, 6:170 http://www.virologyj.com/content/6/1/170
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cell culture as previously described [23]. Viral titer was
assayed by a Vero cell plaque assay (described below), and
was diluted to make the appropriate concentrations for
the aerosol experiments. The viral stock was diluted with
Eagles minimal essential medium (EMEM) (pH = 7.4)
before aerosolization and 10% sterile glycerin was added
to generate larger particles. Glycerin also increased the vis-
cosity of the suspension, which facilitated the formation
of larger particle aerosols in those series of exposures [24].
Exposure System and Aerosol Generation
Mice were exposed to EEEV aerosols in whole-body expo-
sure chambers housed within Class III biological safety
cabinets maintained under negative pressure (-1 WC"), as
previously described [24]. The animals were exposed
inside a whole-body chamber which could contain up to
four smaller stainless steel mesh restraint cages holding
approximately 10 mice/cage or two guinea pigs/cage. The
animal exposures were acute and lasted only 10 min. A
Collison nebulizer (BGI Inc., Waltham, MA) was used to
generate the smaller (1 μm) particles. A spinning-top aer-
osol generator (STAG) was used to generate the larger par-
ticles (BGI USA, Waltham, MA). Total flow through the
inhalation system was 19.0 ± 0.5 liters per min (LPM) dur-
ing the exposures created by the Collison nebulizer; total
flow measured 22 ± 0.5 LPM when the STAG was in use.
The metrics for using both of these generation devices in
association with the inhalation system was previously
described [24]. The test atmosphere in both systems was
sampled during the exposure for size characterization and
aerosol concentration as was previously described. Results
of the particle sizing with the Aerodynamic Particle Sizer
3321 (TSI, Inc, St. Paul, MN) indicated a mass median aer-
odynamic diameter (MMAD) of 1.0 μm and geometric
standard deviation (σg) of 1.3 for the aerosols generated
by the Collison nebulizer. The size distribution for the
particles generated by the STAG was summed as being
composed of distinctly 'larger' particles (> 6 μm) than the
Collison-generated aerosols. Exposure concentration,
expressed in plaque-forming units (PFU)/l, was deter-
mined by isokinetic sampling of the chamber with an all-
glass impinger (AGI; Ace Glass, Vineland, NJ). EMEM
medium with antifoam A 0.001% w/v (Sigma, St. Louis,
MO) was used to collect medium in the impinger. 'Pre-
sented' dose was estimated by calculating the respiratory
minute volume (Vm) using Guyton's formula (Guyton,
1947), expressed as Vm = 2.10 × Wb 
0.75 where Wb = body
weight (g), based upon the average of group weights the
day of exposure. The presented dose was then calculated
by multiplying the estimated total volume (Vt) of experi-
mental atmosphere inhaled by each animal (Vt = Vm ×
length of exposure) by the empirically determined expo-
sure concentration (Ce) ('presented dose' = Ce × Vt).
Plaque Assay
Viral titers in the aerosol generator starting suspensions,
AGI samples, tissues, and blood were determined by
plaque assay as previously described. Tissues obtained at
necropsy were ground with a sterile mortar and pestle and
a 10% homogenate v/w solution was prepared before
viral titration. Briefly, for plaque assay, samples of
homogenized tissue or blood were diluted with a solution
of EMEM with 5% fetal bovine serum (FBS) and gentamy-
cin (without HEPES) added to 6-well plates containing a
confluent monolayer of Vero-E6 cells (green monkey kid-
ney cells) which were incubated at 37°C for 1 hr. Then, a
0.5% agarose overlay in 2× basal medium EMEM with
Earle's salts (EBME) solution (with HEPES salts and 5%
FBS and gentamycin) was added, and plates were incu-
bated at 37°C at 5% CO2 for 48 hr. Thereafter, a second
overlay of saline A (SA) with 5% neutral red and 5% FBS
was added, and the plates were again incubated at 37°C
for 4 hr. Defined plaques (neutral red exclusion areas)
were then counted.
Necropsy & Pathology
Guinea pigs were euthanized at the prescribed time points
in the second experiment by administering an overdose of
Euthasol® (pentobarbital sodium and phenytoin sodium;
Delmarvia Laboratories, Midlothain, VA). A complete
necropsy was conducted on each guinea pig. Heart blood
samples were collected aseptically into pediatric EDTA-
anticogulant evacuated tubes. Samples of cerebrum, lung,
and liver were then obtained aseptically, placed in sterile
centrifuge tubes, and stored at -70°C until processing for
virus isolation. Additionally, a full set of tissue samples
were collected for histopathology. These tissues were fixed
in 10% neutral buffered formalin and stored for a mini-
mum of 21 days within biosafety (BSL)-3 containment to
ensure all virus had been deactivated before histopathol-
ogy processing. Bones were decalcified in formic acid, and
all tissues were trimmed, routinely processed, and embed-
ded in paraffin. Tissue blocks were sectioned at 5-6 μm on
a rotary microtome and mounted on glass slides. All tissue
sections were stained by hematoxylin and eosin. In addi-
tion, duplicate sections were prepared for immunohisto-
chemistry from the lungs, submandibular lymph nodes,
haired skin, salivary glands, brain, and multiple tissues of
the skull. Immunohistochemistry was performed as
described previously [25], with modifications. Briefly, sec-
tions were deparaffinized and rehydrated. Antigen
retrieval was performed by immersing slides in citrate
buffer, pH 6.0, for 30 min at 97°C and endogenous per-
oxidase was blocked. Sections were incubated with the
primary antibody, a polyclonal rabbit antiserum directed
against EEEV, WEEV, VEEV and Sindbis virus (supplied by
Ms. Cindy Rossi, USAMRIID) diluted 1:10,000, for 30
min at room temperature. The remainder of the procedure
utilized a peroxidase-labeled secondary antibody andVirology Journal 2009, 6:170 http://www.virologyj.com/content/6/1/170
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chromogen from a commercial kit (Envision System,
DAKO Inc., Carpinteria, CA) according to the manufac-
turer's instructions. Sections were then rinsed, counter-
stained with hematoxylin, dehydrated, and covered with a
coverslip. Non-immune (normal) rabbit serum was used
as a negative control for the primary antibody.
Statistical Analysis
Dose-response curves were constructed and LD50 values
were determined by probit analysis using PROC PROBIT
in SAS Version 9.1.3 (SAS Institute Inc., Cary, NC, 2007).
Times-to-death were compared by Wilcoxon rank-sum
tests. Descriptive statistics (mean ± standard deviation)
were used to display the results of the tissue and blood
viral titers.
Results
Lethality of aerosolized EEEV in mice and guinea pigs
To examine the lethality of EEEV strains when aero-
solized, Hartley guinea pigs and Balb/c mice were exposed
to either large (> 6 μm) or small (~1 μm) particle aerosol
distributions containing the ArgM or NJ1959 strains of
EEEV (figure 1). Mice and guinea pigs succumbed to the
infection between days 4-8 postexposure (PE) to either
strain of EEEV; there were no significant differences in
time to death between the viral strain, particle size, or
dose of EEEV in either mice or guinea pigs. A generalized
flaccid paralysis was observed in the mice that received the
higher doses (> 1,000 PFU) of the virus, although specific
signs were difficult to distinguish in this species. In guinea
pigs, the initial clinical signs of EEEV infection, including
limited motility and dorsal tremor first appeared (18-24
hr PE) in the guinea pigs exposed to the larger particle aer-
osols. Similar signs of infection were not observed in the
guinea pigs exposed to the smaller distribution (1 μm)
until 65-72 hr PE. Once initial signs of viral infection
began in guinea pigs, the disease progression was similar
for all exposures, and included head tilt, severely altered
gait, and loss of equilibrium. Clinical signs rapidly pro-
gressed to circling, lateral recumbency, and paddling
motions of the forepaw limbs, which culminated with
coma and death.
Analysis of the survival data indicated that the virulence of
aerosolized EEEV was greater in mice than in guinea pigs
(Table 1). Probit analysis of the survival data indicated
that for mice exposed to 1 μm particle size aerosols con-
taining EEEV there was no significant difference in the
lethality of NJ1959 and ArgM (p = 0.1032). At a particle
size > 6 μm, the calculated LD50 for NJ1959 was 2.9 × 103,
almost five times the LD50 for NJ1959 at 1 μm (6.2 × 102)
although this difference was also not significant (p =
0.1057). An LD50 could not be determined for the ArgM
strain at a particle size > 6 μm because mortality was not
≥ 50% in any of the dose groups.
For guinea pigs, the LD50 of 1 μm aerosol particles con-
taining NJ1959 was over 17 times higher than what was
calculated for mice (1.1 × 104 compared to 6.2 × 102,
respectively) (p = 0.0098). The LD50 for the > 3 μm parti-
cles containing NJ1959 was not significantly different
from the LD50 for 1 μm particles of NJ1959 (p = 0.3500)
which is similar to what was observed in the mouse expo-
sures. The LD50 for ArgM at 1 μm was half that of NJ1959
(5.2 × 103 compared to 1.1 × 104, respectively) but an
LD50 could not be calculated for > 6 μm ArgM particles as
≥ 50% mortality was not observed in any of the dose
groups.
Pathogenesis of aerosolized EEEV in guinea pigs
To better define the pathogenesis of aerosolized EEEV in
the guinea pigspecies, we infected groups at a dose of 1.0
× 106 PFU of either NJ1959 or ArgM at 1 μm or > 6 μm
particle distributions. Thereafter, the guinea pigs were
euthanized on days one, two, three or four postexposure
and necropsied to collect tissues for histological examina-
tion and for virus isolation. Four guinea pigs were sam-
pled at each time point for each viral strain/particle size
combination. Regardless of viral strain or particle size,
virus was isolated from all four tissues examined (liver,
lung, brain, and blood) one day after challenge (figure 2).
Virus was only detectable on days one and two postexpo-
sure in the liver and blood except in guinea pigs exposed
to > 6 μm particles of NJ1959 where virus was found in
the blood on day four. For 1 μm exposures, the levels of
NJ1959 were higher than ArgM on day one in the liver,
lungs, and blood although these differences were not sta-
tistically significant. Viral titers in the lungs remained
fairly constant throughout the four days postexposure,
declining slightly on days three and four. In contrast, the
level of virus in the brain increased rapidly throughout the
four days examined for both viral strains and particle dis-
tributions, from 101 PFU/mg on day 1 to 104-106 PFU/g
on day four. The level of virus in the brain on day four was
highest in the guinea pigs exposed to the 1 μm aerosols
containing NJ1959.
Pathology data indicated that productive viral infection of
tissues of infected guinea pigs was almost exclusively lim-
ited to the olfactory segment of the nasal tract and the
brain. Infection of the olfactory segment of the nasal tract
was evident in 11/16 (69%) guinea pigs at day one postex-
posure by positive immunohistochemistry of the olfac-
tory mucosa, the olfactory nerves, and/or the lamina
propria. Both viral strains and both particle sizes resulted
in infection of the olfactory tract at this time. Affected
guinea pigs had one or more foci of immunolabeled olfac-
tory mucosa scattered throughout the nasal tract, often
associated with positive olfactory nerves and lamina pro-
pria. The foci that contained EEEV antigen were without
apparent morphological changes in infected cells of allVirology Journal 2009, 6:170 http://www.virologyj.com/content/6/1/170
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Survival of guinea pigs and mice after aerosol exposure to EEEV Figure 1
Survival of guinea pigs and mice after aerosol exposure to EEEV. Guinea pigs (top graphs) and mice (bottom graphs) 
were exposed to different doses of NJ1959 (first and third row graphs) or ArgM (second and fourth row graphs) at 1 μm (left 
column) or > 6 μm particle sizes (right column). Graphs show percent survival (y axis) for each group for each day postchal-
lenge (x axis).
 Virology Journal 2009, 6:170 http://www.virologyj.com/content/6/1/170
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cases at day one. At day two postexposure, the olfactory
tracts of 15/16 (94%) guinea pigs exhibited positive
immunohistochemical staining for viral antigen (Figure
3A). In individual cases, there was more extensive labeling
of EEEV antigen in the olfactory tract than was evident in
any of the cases euthanized at day one postexposure.
However, some guinea pigs had only minimal antigen at
day two and even those with the most abundant antigen
labeling demonstrated infection of only a minor percent-
age of the olfactory neuroepithelium. Many of the
infected cells were identified as olfactory neurons by the
presence of viral antigen within both the cell body and the
apical processes. Basal cells also contained antigen in
some cases, as did apparent macrophages and fibroblasts
in the lamina propria. The possibility that sustentacular
cells were also infected could not be ruled out, but it was
not possible to identify these cells morphologically in
immunostained slides. Another feature apparent in some
animals was positive immunostaining of segments of
olfactory mucosa that ended abruptly at the junction with
respiratory mucosa. The respiratory epithelium was uni-
formly negative in all guinea pigs. This finding implied a
tropism of aerosolized EEEV for olfactory cells but not res-
piratory cells. At day two postexposure, some immunola-
beled foci of olfactory mucosa had a few degenerate or
apoptotic cells and minimal infiltrates of heterophils;
however, most positive foci remained morphologically
unaffected at the light microscopy level. The majority of
guinea pigs euthanized at days threee and four postexpo-
sure had small amounts of EEEV antigen in the olfactory
tract. At these time points, the morphological changes in
affected olfactory tract were more prominent than on day
one or two postexposure and included focal to segmental
degeneration and cell death in the olfactory mucosa and
infiltration of affected foci by heterophils. Affected cells in
the olfactory mucosa were characterized by peripheral
nuclear condensation, nuclear fragmentation, and the
presence of apoptotic bodies in the olfactory mucosa,
indicating that a significant proportion of the dead cells
had undergone apoptosis.
Infection of the brains of guinea pigs was first evident by
the presence of limited EEEV antigen within the lamina
fibrorum and lamina glomerulosa of the olfactory bulbs
of 5/16 (31%) guinea pigs at day one postexposure. His-
tologically, the olfactory bulbs did not exhibit abnormal
changes on day one. At day two postexposure, abundant
viral antigen was present throughout all layers of the
olfactory bulbs of all guinea pigs and the meninges of the
olfactory bulbs were minimally to mildly thickened by
infiltrates of macrophages, lymphocytes, and some heter-
ophils at this time point and at later time points (Figure
3B). There was minimal hemorrhage in the olfactory
bulbs of a few guinea pigs at day two postexposure. Virus
antigen was also present in the brain proper of 15/16
(93%) guinea pigs at day two postexposure. Antigen, pri-
marily in neurons, was limited to the olfactory structures
in the rostral brain at this time, including the olfactory
Table 1: Particle size and viral strain specific LD50 determination, by speciess




ArgM 1 5.2E+03 2.9E+03 2.4E+04 6.0
> 3b n/cc -d -5 . 0
NJ1959 1 1.1E+04 3.5E+03 8.9E+04 5.0
> 3 3.0E+04 9.1E+03 7.6E+05 5.8
mouse
BALB/c
ArgM 1 4.6E+02 1.9E+02 1.7E+03 6.0
> 3 n/cc -- 4 . 7
NJ1959 1 6.2E+02 - - 5.8
> 3 2.9E+03 1.1E+03 1.1E+04 5.8
a Mean time to death
b Considered 'larger' particle distribution due to bimodal size distribution
c LD50 could not be estimated because no dose group had more than 50% mortality
d The confidence limits were not determined due to lack of mortality in selected groupsVirology Journal 2009, 6:170 http://www.virologyj.com/content/6/1/170
Page 7 of 13
(page number not for citation purposes)
tubercles, olfactory nuclei, and pyriform cortices. The
meninges overlying the olfactory portion of the brain in
several animals contained minimal infiltrates of macro-
phages, lymphocytes, and some heterophils. At day three
postexposure, abundant viral antigen was present in the
olfactory nuclei and pyramidal layer of the olfactory
tubercles and in the pyriform cortices of all animals, again
predominantly within neurons (Figure 3C). In addition,
there was often extensive viral antigen in the periventricu-
lar cells of the lateral ventricles (Figure 3D). Less fre-
quently, neurons in the neocortex, thalamus,
hippocampus, and basal nuclei were positive by immuno-
histochemistry. At day 3, there was infiltration of the
neuropil in the pyramidal layer of the olfactory tubercles
and pyriform cortex by numerous heterophils, many of
which were degranulated and/or degenerate. Neurons in
affected areas appeared shrunken and a few had hypere-
osinophilic cytoplasm. Blood vessels in these areas and in
the basal nuclei were often lined by hypertrophied
endothelium and the Virchow-Robbins space contained
macrophages and heterophils that in some cases formed
cuffs of up to three cell layers. The walls of a few blood
Viral load in guinea pig tissues after aerosol exposure to EEEV Figure 2
Viral load in guinea pig tissues after aerosol exposure to EEEV. Guinea pigs were exposed to aerosolized EEEV strains 
NJ1959 (open symbols) or ArgM (filled symbols) at a dose of 1 × 106 PFU; each day four guinea pigs from each group were 
necropsied and samples of liver (A), brain (B), lung (C) or blood (D) were taken for virology. Graphs showed averaged viral load 
in PFU/g ± the standard deviation for each day postexposure.Virology Journal 2009, 6:170 http://www.virologyj.com/content/6/1/170
Page 8 of 13
(page number not for citation purposes)
Figure 3 (see legend on next page)Virology Journal 2009, 6:170 http://www.virologyj.com/content/6/1/170
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vessels were disrupted or fragmented and were infiltrated
by viable and degenerate inflammatory cells mixed with
erythrocytes, indicating early vasculitis. The meninges of
the olfactory tubercles and pyriform cortex at this time
were edematous and contained infiltrates of macro-
phages, heterophils and lymphocytes. Meningeal inflam-
mation extended from the olfactory portion of the brain
locally into the neocortex in some cases. At day four pos-
texposure, viral antigen was again most extensive in the
olfactory structures of the brain, but was increased in
other locations as well. Antigen was seen in large motor
neurons of the caudal brainstem of 3/16 (19%) animals
and in Purkinje neurons of the cerebellum of 2/16 (12%)
animals. At day four, many pyramidal neurons in the
olfactory tubercles and pyriform cortex were necrotic and
these areas had extensive infiltration by heterophils with
fewer mononuclear cells, admixed with cellular debris
(Figure 3E). There was vasculitis in these areas, and also in
the basal nuclei, septum, and neocortex that was more
severe than at day three. Rarely, there was fibrinoid necro-
sis of vessels (Figure 3F) at day 4 PE. The neuropil also
contained scattered microhemorrhages at day four and
there was prominent inflammation surrounding the lat-
eral ventricles in animals in which periventricular antigen
was present. In addition to neurons, a few cells that
appeared to be glial cells, degenerate neurons, or possibly
inflammatory cells contained viral antigen. Ependymal
lining cells rarely contained antigen, and antigen was
present in cells in the lumens of some lateral ventricals
that appeared to be macrophages.
Neurons were the primary target of EEEV in the brains of
infected guinea pigs. In particular, EEEV showed tropism
for medium to large neurons such as pyramidal neurons
in the neocortex, Purkinje neurons, and motor neurons in
the brainstem. In addition, some scattered smaller cells in
the brain, possibly small neurons and/or glial cells, also
contained viral antigen, as did some apparent inflamma-
tory cells and the previously mentioned periventricular
cells. Neither the strain of EEEV, nor the size of aerosol
particles with which guinea pigs were infected appeared to
have any effect on how rapidly virus appeared in the olfac-
tory mucosa or the brain. However, at day two, subjec-
tively there did appear to be slightly more antigen in both
the olfactory mucosa and rostral brain of guinea pigs
infected with large particle aerosols than with small parti-
cle aerosols.
Minimal amounts of viral antigen were present in the
lungs of some guinea pigs infected with the NJ1959 strain
of EEEV (Figure 3G), but viral antigen was not evident in
any of the animals infected with the ArgM strain. In the
guinea pigs infected with the large particle NJ1959 strain,
only a single animal, euthanized at day one postexposure,
had minimal viral antigen in the lumen of a small airway.
In those animals infected with the small-particle NJ1959
strain, all four animals at day one postexposure had viral
antigen in the lungs and two of the four animals at day
two had positive lungs. The lungs of the remaining ani-
mals were negative which included the lungs of all 32
guinea pigs euthanized at days three and four. In the pos-
itive lungs, viral antigen was present either in the epithe-
lium lining conducting airways measuring 50-150 μm,
interpreted as small bronchi or bronchioles, or in alveoli.
Some of these foci exhibited degeneration or apoptosis of
the few positive cells and some affected cells were
sloughed into the lumens of small airways. These were the
only histological changes that we associated with EEEV
infection of the lungs; however, the lungs of many of the
guinea pigs contained scattered foci of macrophages, lym-
phocytes, and some heterophils consistent with inflam-
mation due to inhaled particulate material, i.e.,
pneumoconiosis.
Additional immunohistochemistry findings included rare
positive cells that appeared to be osteoblasts in the skulls
of four guinea pigs, small foci of positive subgingival or
periodontal connective tissue in three cases and a focus of
positive odontoblastic epithelium in a single case. Other-
wise, the structures of the head, including the mandibular
Pathogenesis of EEEV in guinea pigs after aerosol exposure Figure 3 (see previous page)
Pathogenesis of EEEV in guinea pigs after aerosol exposure. (A) EEEV antigen was present in a segment of olfactory 
neuroepithelium, but not in the adjacent respiratory epithelium, of a guinea pig 48 hr after exposure. The junctions of olfactory 
mucosa and respiratory mucosa are demonstrated by the arrows. (B) EEEV antigen is present in the olfactory bulb of a guinea 
pig 72 hr after exposure. Note the disruption of the neuropil and the infiltration of the neuropil and meninx by inflammatory 
cells. (C) EEEV antigen was present in the cell bodies and neuritic processes of several neurons in the brain of a guinea pig 72 hr 
after exposure. (D) In the brain of the same guinea pig as in Figure 3C, there is abundant viral antigen throughout the pyriform 
cortex (*'s) and the deeper basal nucleus, as well as in the periventricular cells (arrow). (E) Abundant inflammatory cells 
thicken the meninx overlying the pyriform cortex (*), form cuffs around blood vessels in the basal nucleus (arrows) and also 
infiltrate the neuropil (arrowhead) of a guinea pig 96 hr after exposure. (F) In the brain of the same guinea pig as in Figure 2E, 
the wall of an inflamed blood vessel is disrupted, infiltrated by inflammatory cells and contains eosinophilic (fibrinoid) material 
(arrowheads). Also, note the perivascular hemorrhage (arrow). (G) Minimal viral antigen is present in the lung of a guinea pig 48 
hr after exposure.Virology Journal 2009, 6:170 http://www.virologyj.com/content/6/1/170
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lymph nodes, the nasal-associated lymphoid tissues, and
the vomeronasal organs, did not exhibit positive immu-
nostaining for EEEV antigen, nor was there histological
evidence of viral infection of other tissues. In particular,
there was no evidence of viral infection of the respiratory
lining cells of the nasal tract, nor the tracheas, of any
guinea pigs in the study. Evidence of EEEV infection of
other tissues, including the heart, liver, spleen, kidneys,
adrenal glands, stomach, small and large intestines, pan-
creas, urinary bladder, testes, ovaries, uterus, skin, salivary
glands, thymus, bone marrow, and mediastinal and
mesenteric lymph nodes, was uniformly lacking. In addi-
tion to pneumoconiosis, lesions considered to be com-
mon findings in guinea pigs were seen in some cases.
Changes consistent with vitamin C deficiency were evi-
dent in the tibia and femur of most guinea pigs in the
study. In several guinea pigs, rhabdomyomatosis was
present in the heart and/or mild changes consistent with
early segmental nephrosclerosis were present in the kid-
neys.
Discussion
This study was performed to further assess the relative
infectivity of EEEV as an aerosol, to assess the comparative
virulence of representative North and South American
strains of EEEV when aerosolized, and to initiate charac-
terization of rodent models of aerosol disease to be used
in future testing of medical countermeasures against
EEEV. In the initial exposure experiments, lethality esti-
mates were established in both animal species, although
mortality in the groups did not consistently match the
increase in dose received. This variation may account for
the lack of fiducial limits in some of the probit analysis. In
a previous pathogenesis study using juvenile albino mice
inoculated intracranially or subcutaneously with EEEV
strains E-1 and P-7, a sharp dose-response curve was
observed, although the doses were simply reported as an
inoculating volume of 20% brain suspension homoge-
nate from experimentally infected suckling mice, which
allows no basis for comparison [14]. Other subsequent
investigative studies with intracranially inoculated pigs
failed to establish a dose-response relationship with the
virus [12]. The clinical signs of animals in the current
study, manifesting as partial to complete paralysis in the
mice and asymmetrical neurological signs in the guinea
pigs, temporally matched the similar onset of signs
observed in intracranially infected domestic pigs. Clinical
signs in a single calf experimentally infected with EEEV-
infected brain homogenate were similar to those observed
in the rodent and pigs, including nystagmus and dorsal
tetanic spasm, 3 days after onset of disease [13].
In this study, the guinea pigs proved to be the better
model for EEEV infection than mice, in that they devel-
oped more uniform clinical signs with an easily identified
onset and lethality in the lethal dose determination. Later
stages in the clinical illness (coma, death) illustrated what
is typically observed in encephalitic syndromes caused by
neutrotropic viruses. Clinical signs were difficult to assess
in mice until very late in the course of the disease. Ham-
sters are the alternative rodent model for studying EEEV
infection. At this time, we cannot distinguish whether
guinea pigs or hamsters are the superior model since both
develop pathologies similar to what has been reported to
humans, particularly the development of vasculitis [20].
However, it should be noted that guinea pigs and ham-
sters were infected by different routes of exposure (aerosol
exposure and subcutaneous inoculation, respectively)
which can alter the pathogenesis of the disease. Because
guinea pigs have been evaluated for aerosol exposure, we
believe them to be the superior model for evaluating the
efficacy of candidate vaccines or therapeutics for the aero-
sol route of exposure.
It was expected that particle size distribution would alter
the virulence and pathogenesis of aerosolized EEEV. The
anatomical differences in the respiratory tract of a guinea
pig when compared to a mouse would affect particle dep-
osition and subsequent initiation of disease. Larger aero-
sol particles of EEEV with a MMAD of > 6 μm would be
expected to deposit more in the upper respiratory tract,
leading to infection of the olfactory neuroepithelium and
the olfactory bulb and more rapid penetration into the
brain of exposed animals than would be the case for aero-
sol exposure to EEEV in a smaller, more highly respirable
particle. Exposure to a larger particle size would be
expected to lower the dose required to cause disease and
potentially accelerate the progression of the infection
[24]. It was surprising then, that the LD50 for both strains
of EEEV was higher for aerosol exposures at the larger par-
ticle size and could not be determined for the ArgM strain
in mice. We pursued the serial sacrifice studies in the
guinea pig model to examine the pathogenesis of aero-
solized EEEV infection as a result of these initial findings
in the lethality estimation experiements
Our observation of early infection of the olfactory neu-
roepithelium seems to represent a cardinal feature in the
pathogenesis of aerosolized EEEV in guinea pigs. In partic-
ular, EEEV infection of the so-called bipolar olfactory neu-
rons is key, because at one 'pole' these cells have ciliary
processes that extend into the air passages, where they
likely contact virus, and at the opposite 'pole' they extend
axons that synapse directly with neurons in the olfactory
bulbs. Viruses that target the olfactory neurons therefore
have a direct portal to the brain. The additional finding of
early infection of olfactory neurons in guinea pigs
exposed to both small- and large-particle aerosols, how-
ever, fails to explain why the guinea pigs exposed to large
particle aerosols had higher LD50. Given the observedVirology Journal 2009, 6:170 http://www.virologyj.com/content/6/1/170
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infection of the olfactory neurons by EEEV, it was not
unexpected that infection of the brain was first evident as
viral antigen within the olfactory bulbs and other olfac-
tory brain structures. This was followed by apparent tran-
sneuronal spread to other parts of the brain in generally a
rostral to caudal fashion, reaching the caudal brainstem
and cerebellum of a few guinea pigs by day four which
was the last day studied. Viral infection of the brain
resulted in direct damage to neurons as well as widespread
meningoencephalitis. These important pathogenetic fea-
tures, infection of olfactory neuroepithelium, invasion of
the olfactory brain, transneuronal spread, direct neuronal
cytopathicity, and inflammation of the brain, are essen-
tially identical to the mouse model of aerosolized VEEV,
to date the best characterized animal model of aerosolized
alphavirus infection [2,17-19].
There were some differences between the mouse model of
aerosolized VEEV and the characteristics of EEEV infection
seen in our current studies with guinea pigs. Exposure to
aerosolized VEEV causes massive infection of the olfactory
neuroepithelium in mice, [18,19] whereas aerosolized
EEEV infection was apparent only in a few usually small
foci of the olfactory neuroepithelium of guinea pigs. This
finding in guinea pigs is similar to previous studies in our
laboratory with attenuated VEEV strains in which limited
productive infection of the neuroepithelium by the atten-
uated viruses was nonetheless sufficient to result in viral
entry into the brain [18]. This aspect is relevant to efforts
to develop vaccines effective against aerosolized alphavi-
ruses and punctuates that even small amounts of virus
that might evade local immune mechanisms in the olfac-
tory tract could be sufficient to infect the brain. Another
difference noted in this study is that productive infection
due to aerosolized EEEV was apparent only in the olfac-
tory neuroepithelium and the brains of guinea pigs,
whereas VEEV infection of mice appears to have some-
what broader tropism, consistently infecting Bowman's
glands, the teeth, vomeronasal organs, the pancreas and,
importantly, lymphoid tissues. Neither EEEV in this study,
nor VEEV in previous studies, appeared to result in sus-
tained infection of the respiratory epithelia in the lungs
and upper respiratory tract of guinea pigs and mice,
respectively. This particular feature is likely of little impor-
tance however, given the significant susceptibility of the
olfactory neuroepithelium, and the consequences thereof,
as previously discussed.
There were also similarities and differences between the
guinea pigs in this study and other animal models of EEEV
that utilized peripheral inoculation of this virus. Key
among the similarities, cutaneous inoculation of young
mice [14,15] and golden hamsters [20] with EEEV
resulted in neuroinvasion, targeting of neurons, and wide-
spread infection of the brain leading to death. However,
in both the mice and hamsters infected with EEEV cutane-
ously, virus appeared in multiple regions of the brain
simultaneously, indicating neuroinvasion by a vascular
route. This is in contrast to the guinea pigs in our study, in
which neuroinvasion appeared to occur via the olfactory
tract. A reported feature of golden hamsters infected with
EEEV which is possibly relevant to human infections with
EEEV is that, unlike mice, they develop vasculitis [20]. We
also observed vasculitis as a late-developing feature of
meningoencephalitis in the guinea pigs inoculated with
aerosolized EEEV. However, the significance of vasculitis
relative to human cases of EEEV is uncertain. While vascu-
litis can certainly contribute to the overall brain damage
that occurs in EEEV, it may be of limited consequence
with regard to the ultimate cause of death, especially given
that neurons are collectively an overwhelming target of
viral infection and appear to suffer from direct viral dam-
age.
Two other particular features of EEEV infection of the
guinea pigs in this study merit discussion. First, we did not
observe tropism of EEEV for lymphoid tissues and little, if
any, viral antigen within macrophages in any tissues.
Studies with mice and hamsters also reported limited lym-
phoid tropism by EEEV [15,20]. These findings are in con-
trast to findings in experimental animal models with
VEEV, where that virus is strongly tropic for lymphoid tis-
sues and causes severe lymphoid necrosis [2,18,19,26].
Infection of macrophages may be central to the lymphoid
damage caused by VEEV [27]. Hamsters and guinea pigs,
as well as rabbits, develop such severe necrosis of lym-
phoreticular tissues after inoculation with VEEV that they
die from bacterial overgrowth and endotoxic shock before
full manifestation of central nervous system infection
[2,26]. This has significantly limited the utility of these
three species as experimental models of VEEV. The lack of
lymphoid tropism exhibited by EEEV is therefore presum-
ably necessary for the manifestation of neurological infec-
tion in hamsters and guinea pigs when virus is inoculated
peripherally. The second feature of EEEV infection of
guinea pigs worth discussing regards the matter of infec-
tion of osteoblasts. It was recently reported that osteob-
lasts are an important early target of EEEV in young mice
and it was postulated that this might contribute to the
greater sensitivity of the young to infection with this virus
[15]. We also observed a few cells with EEEV antigen in
the skulls of guinea pigs that appeared to be osteoblasts;
however, these cells were rare. This difference in osteob-
last susceptibility between guinea pigs and mice infected
with EEEV could be due to species differences, the ages of
the animals used in the two studies or other factors. A vari-
ety of additional pathogenetic features in animal models
of alphavirus infection have also been described, but
additional comparisons to those studies are beyond the
scope of this report.Virology Journal 2009, 6:170 http://www.virologyj.com/content/6/1/170
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An additional aim of this study was to determine the vir-
ulence and pathogenesis of a South American strain of
EEEV. South American strains of EEEV are antigenically
distinct from North American strains and vaccines against
North American strains may not be protective [6]. South
American EEEV strains are thought to be less virulent than
North American strains; however, enzootic subtypes of
VEEV that cause only mild disease by subcutaneous inoc-
ulation can cause significant morbidity and encephalitis
in animals when aerosolized [28]. This variation in viru-
lence as a result of exposure raised concern that South
American strains of EEEV might also be more virulent by
aerosol. The results reported here indicate that a South
American strain of EEEV was as virulent by inhalation as a
North American strain that has caused disease in humans.
Therefore, vaccines or therapeutics developed to protect
against aerosol exposure to EEEV should be evaluated
against both North American and South American strains.
In summary, mice and guinea pigs are susceptible to lethal
infection by North and South American strains of EEEV.
The guinea pig model of aerosolized EEEV recapitulates
several key features of fatal human infection by EEEV. It
also shares several important pathogenic features with
aerosolized VEEV infection in mice. Thus, guinea pigs
should serve as a useful animal model for aerosol expo-
sure to alphaviruses in general, and for EEEV in particular.
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